SCHEMBL16618815

SCHEMBL16618815

COCCOc1cc2c(NC(C)c3ccccc3)c([N+](=O)[O-])cnc2cc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
KRAS P01116 1/20 0.39
SOS1 Q07889 1/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
ERBB2 P04626 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16618812 1.00 EGFR (0.39) EGFRALDH1A1GAAHTTKRAS
SCHEMBL16619605 0.90 SOS1 (0.47) EGFRALDH1A1GAAHTTKRAS
SCHEMBL16619606 0.90 SOS1 (0.47) EGFRALDH1A1GAAHTTKRAS
SCHEMBL16619574 0.86 EGFR (0.39) EGFRALDH1A1GAAHTTKRAS
SCHEMBL16619572 0.86 EGFR (0.39) EGFRALDH1A1GAAHTTKRAS
SCHEMBL16618856 0.86 EGFR (0.42) EGFRALDH1A1GAAKRASSOS1
SCHEMBL16618852 0.86 EGFR (0.42) EGFRALDH1A1GAAKRASSOS1
SCHEMBL16619217 0.83 ALDH1A1 (0.49) EGFRALDH1A1GAAHTTCRHBP
SCHEMBL16619219 0.83 ALDH1A1 (0.49) EGFRALDH1A1GAAHTTCRHBP
SCHEMBL16619416 0.80 KDM4E (0.46) ALDH1A1GAAHTTHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049629-A1 IMIDAZOQUINOLINE COMPOUNDS AS BROMODOMAIN INHIBITORS Piramal Enterprises Limited (IN) 2015-04-09 WO disclosed